China Health Industries Holdings Inc
China Health Industries Holdings, Inc., through its subsidiaries, manufactures and sells health products. The company operates through three segments: Humankind, HLJ Huimeijia, and Others. The company offers hemp derivative products, such as hemp oil, hemp protein powder, hemp polypeptides, collagen peptides, hemp essence repair lotions, hemp revitalizing essence products, hemp anti-aging brighte… Read more
China Health Industries Holdings Inc (CHHE) - Net Assets
Latest net assets as of March 2024: $-2.40 Million USD
Based on the latest financial reports, China Health Industries Holdings Inc (CHHE) has net assets worth $-2.40 Million USD as of March 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($4.13 Million) and total liabilities ($6.53 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-2.40 Million |
| % of Total Assets | -58.05% |
| Annual Growth Rate | 30.14% |
| 5-Year Change | 5.18% |
| 10-Year Change | 8.48% |
| Growth Volatility | 351.64 |
China Health Industries Holdings Inc - Net Assets Trend (2006–2023)
This chart illustrates how China Health Industries Holdings Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for China Health Industries Holdings Inc (2006–2023)
The table below shows the annual net assets of China Health Industries Holdings Inc from 2006 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-06-30 | $39.11 Million | -8.63% |
| 2022-06-30 | $42.80 Million | -4.40% |
| 2021-06-30 | $44.77 Million | +12.87% |
| 2020-06-30 | $39.67 Million | +6.68% |
| 2019-06-30 | $37.18 Million | +5.50% |
| 2018-06-30 | $35.24 Million | +1.55% |
| 2017-06-30 | $34.71 Million | +1.34% |
| 2016-06-30 | $34.25 Million | -5.76% |
| 2015-06-30 | $36.34 Million | +0.81% |
| 2014-06-30 | $36.05 Million | -32.55% |
| 2013-06-30 | $53.45 Million | +2.46% |
| 2012-06-30 | $52.16 Million | +40.85% |
| 2011-06-30 | $37.03 Million | +106.77% |
| 2010-06-30 | $17.91 Million | +316.28% |
| 2009-06-30 | $4.30 Million | +1440.78% |
| 2007-06-30 | $279.24K | -37.08% |
| 2006-06-30 | $443.81K | -- |
Equity Component Analysis
This analysis shows how different components contribute to China Health Industries Holdings Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 4171329500.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (June 2023)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $41.29 Million | 105.57% |
| Common Stock | $6.55K | 0.02% |
| Other Comprehensive Income | $-2.71 Million | -6.92% |
| Other Components | $521.99K | 1.33% |
| Total Equity | $39.11 Million | 100.00% |
China Health Industries Holdings Inc Competitors by Market Cap
The table below lists competitors of China Health Industries Holdings Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
PCCW (TH3B.SG)
STU:TH3B
|
$6.56K |
|
TEXHONG TEXTILE GRP HD-10
F:T1TA
|
$6.56K |
|
PSVM11F
SA:PSVM11F
|
$6.57K |
|
SOCIETE GENERALE GHANA LIMITED
GSE:SOGEGH
|
$6.57K |
|
Enigma-Bulwark Ltd.
OTCMKTS:EBWK
|
$6.55K |
|
FIRST PACIFIC
MU:FPC
|
$6.54K |
|
Cannonau Corp
PINK:CNNC
|
$6.53K |
|
TRAVEL24.COM (TVD6.SG)
STU:TVD6
|
$6.53K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in China Health Industries Holdings Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 42,802,719 to 39,109,569, a change of -3,693,150 (-8.6%).
- Net loss of 409,000 reduced equity.
- Other comprehensive income decreased equity by 3,284,378.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-409.00K | -1.05% |
| Other Comprehensive Income | $-3.28 Million | -8.4% |
| Other Changes | $228.00 | +0.0% |
| Total Change | $- | -8.63% |
Book Value vs Market Value Analysis
This analysis compares China Health Industries Holdings Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.34x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 0.82x to 0.34x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-06-30 | $0.24 | $0.20 | x |
| 2007-06-30 | $0.14 | $0.20 | x |
| 2009-06-30 | $0.07 | $0.20 | x |
| 2010-06-30 | $0.29 | $0.20 | x |
| 2011-06-30 | $0.59 | $0.20 | x |
| 2012-06-30 | $0.84 | $0.20 | x |
| 2013-06-30 | $0.86 | $0.20 | x |
| 2014-06-30 | $0.58 | $0.20 | x |
| 2015-06-30 | $0.58 | $0.20 | x |
| 2016-06-30 | $0.52 | $0.20 | x |
| 2017-06-30 | $0.53 | $0.20 | x |
| 2018-06-30 | $0.54 | $0.20 | x |
| 2019-06-30 | $0.57 | $0.20 | x |
| 2020-06-30 | $0.61 | $0.20 | x |
| 2021-06-30 | $0.68 | $0.20 | x |
| 2022-06-30 | $0.65 | $0.20 | x |
| 2023-06-30 | $0.60 | $0.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently China Health Industries Holdings Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -1.05%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -366.56%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.15x
- Recent ROE (-1.05%) is below the historical average (5.24%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | -86.07% | -51.13% | 0.91x | 1.85x | $-426.38K |
| 2007 | -59.29% | -19.66% | 1.20x | 2.52x | $-193.47K |
| 2009 | 65.64% | 25.75% | 1.16x | 2.20x | $2.39 Million |
| 2010 | 74.00% | 30.75% | 1.93x | 1.25x | $11.46 Million |
| 2011 | 47.73% | 28.15% | 1.48x | 1.14x | $13.97 Million |
| 2012 | 27.75% | 24.56% | 1.10x | 1.03x | $9.26 Million |
| 2013 | -1.03% | -7.16% | 0.14x | 1.02x | $-5.90 Million |
| 2014 | -1.83% | -6.78% | 0.24x | 1.13x | $-4.26 Million |
| 2015 | 0.01% | 0.03% | 0.25x | 1.14x | $-3.63 Million |
| 2016 | 0.47% | 2.04% | 0.19x | 1.18x | $-3.27 Million |
| 2017 | 3.78% | 20.59% | 0.15x | 1.20x | $-2.16 Million |
| 2018 | -0.90% | -4.84% | 0.15x | 1.22x | $-3.84 Million |
| 2019 | 8.89% | 35.65% | 0.20x | 1.23x | $-411.25K |
| 2020 | 8.95% | 35.75% | 0.21x | 1.22x | $-415.80K |
| 2021 | 2.88% | 19.88% | 0.12x | 1.20x | $-3.19 Million |
| 2022 | -0.83% | -132584.27% | 0.00x | 1.19x | $-4.63 Million |
| 2023 | -1.05% | -366.56% | 0.00x | 1.15x | $-4.32 Million |
Industry Comparison
This section compares China Health Industries Holdings Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| China Health Industries Holdings Inc (CHHE) | $-2.40 Million | -86.07% | N/A | $6.55K |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |